MEDICAMEN has announced the establishment of a new Research & Development (R&D) center, marking a significant step in innovation and product development. In addition, the company has undertaken the upgradation and modernization of its Bhiwadi Finished Dosage Forms (FDF) plant, enhancing production capabilities and ensuring adherence to the latest industry standards. These initiatives underscore the company’s commitment to advancing healthcare solutions and expanding its operational capacity.
Copyright © 2023, MEDICAMEN BIOTECH LIMITED. All Rights Reserved. Designed by Rautela Tech
Share This News